Panel Testing for Hereditary Breast Cancer: More or Less? Kara K. LandryMarie E. Wood Breast Cancer Genetics (BK Arun, Section Editor) 20 May 2020 Pages: 45 - 50
Health Disparities in Germline Genetic Testing for Cancer Susceptibility Divya A. ParikhJames C. DickersonAllison W. Kurian Breast Cancer Genetics (B Arun, Section Editor) 12 February 2020 Pages: 51 - 58
Implications of BRCA Germline Mutations on Breast Cancer Medical Treatment Fanny Le DuAngélique BrunotVéronique Diéras Breast Cancer Genetics (BK Arun, Section Editor) 06 April 2020 Pages: 59 - 65
Risk Management for BRCA1/BRCA2 Mutation Carriers Without and With Breast Cancer C. B. MainorC. Isaacs Breast Cancer Genetics (B Arun, Section Editor) 17 February 2020 Pages: 66 - 74
DCIS: Radiation Considerations Puyao C. LiRinaa S. Punglia Non-Invasive Breast Cancer Diagnosis and Treatment (ES Hwang, Section Editor) 18 February 2020 Pages: 75 - 81
Treatment from within: Ductal Carcinoma as an Opportunity to Harness the Immune System Justin G. WilkesBrian J. CzernieckiRicardo L. B. Costa Non-Invasive Breast Cancer Diagnosis and Treatment (ES Hwang, Section Editor) 17 February 2020 Pages: 82 - 89
Ductal Carcinoma In Situ (DCIS): the Importance of Patient-Reported Outcomes (PRO) Laura S. DominiciShoshana M. Rosenberg Non-Invasive Breast Cancer Diagnosis and Treatment (ES Hwang, Section Editor) 20 April 2020 Pages: 90 - 97
Treatment of Ductal Carcinoma In Situ: Considerations for Tailoring Therapy in the Contemporary Era Anita MamtaniKimberly J. Van Zee Non-Invasive Breast Cancer Diagnosis and Treatment (ES Hwang, Section Editor) 24 February 2020 Pages: 98 - 106
Ductal Carcinoma In Situ—Pathological Considerations Baljit Singh Non-Invasive Breast Cancer Diagnosis and Treatment (ES Hwang, Section Editor) 20 February 2020 Pages: 107 - 117
Breast Self-Examination: the Case for a Second Look Eric DietzeVeronica JonesVictoria Seewaldt Hot Topic 26 February 2020 Pages: 118 - 124